Cancer vaccine (Immunovative Therapies)

N/A

Report date: 2025/10/24 20:00:54

Base Information

Drug NameCancer vaccine (Immunovative Therapies)
Drug Alias Name肿瘤疫苗 (Immunovative Therapies)AlloStim-9癌症疫苗 (Immunovative Therapies)AlloStim-8AlloStim-7 +[12] 
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Metastatic breast cancerSolid tumours +[22] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesThailandIsrael +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesImmunovative Therapies Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMirror Biologics Inc
Inactive CompaniesMichael Har-NoyImmunovative Therapies Ltd
Active IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Distress Syndrome, AdultColorectal Neoplasms +[7] 
Inactive IndicationsMetastatic breast cancerSolid tumoursProstatic Neoplasms +[15] 

Other Information

ATC CodeN/A
Related LinksN/A